orthofix
-
Biologics
Orthofix Announces New President for Bone Growth Therapies Business
LEWISVILLE, Texas, February 29, 2024 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced…
Read More » -
Spine
Orthofix Announces Commercial Partnership with MRIguidance
First radiation-free spine procedures using pre-operative MRI completed with the 7D FLASH Navigation System and BoneMRI Technology LEWISVILLE, TEXAS, January…
Read More » -
Financial
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
Net sales of $200.3 million, an increase of 64% on a reported basis and an increase of 8% on a…
Read More » -
Biologics
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Massimo Calafiore begins as President and Chief Executive Officer, effective immediately Julie Andrews is appointed as Chief Financial Officer, assuming…
Read More » -
Spine
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
LEWISVILLE, Texas, December 21, 2023–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication…
Read More » -
Extremities
Orthofix Donates Medical Equipment to Global Nonprofit Steps2Walk, Inc.
Orthopedic devices and equipment will help patients in under-served regions around the world with severe ankle and foot deformities DENVER, Dec.…
Read More » -
Extremities
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
Three New Directors Bring Substantial Finance, Strategic Development, Healthcare and MedTech Experience LEWISVILLE, Texas, December 12, 2023 — (BUSINESS WIRE)–Orthofix…
Read More » -
Biologics
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient…
Read More » -
Spine
Orthofix Names Massimo Calafiore as President and Chief Executive Officer
Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive…
Read More » -
Spine
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures
LEWISVILLE, Texas, November 6, 2023–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full…
Read More » -
Spine
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
LEWISVILLE, TX, October 12, 2023 /OrthoSpineNews/ Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k…
Read More » -
Extremities
Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures
LEWISVILLE, Texas, September 20, 2023 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the…
Read More » -
Regulatory
Orthofix Announces Leadership Changes
Catherine Burzik Appointed Interim Chief Executive Officer Geoffrey Gillespie Appointed Interim Chief Financial Officer Puja Leekha Appointed Interim Chief Legal…
Read More » -
Spine
Orthofix Announces First Cases and Full Commercial Launch of the 7D FLASH Navigation System Percutaneous Module 2.0 for Minimally Invasive Surgery
Image of the 7D FLASH™ Navigation System with the Percutaneous Module 2.0 for minimally invasive surgeries. The system uses visible…
Read More » -
Financial
Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance
Net sales of $187.0 million, an increase of 58% on a reported basis and 7% on a pro forma constant…
Read More »